Boston Scientific Corporation has announced the global launch of its Journey Guidewire, an innovative 0.014” guidewire designed for use in challenging, small vessel peripheral angioplasty procedures. The Journey Guidewire strengthens Boston Scientific’s broad portfolio of devices designed to address physician needs in treating arteries below the knee.
James Benenati, medical director of the Baptist Cardiac and Vascular Institute in Miami, and president of the Society of Interventional Radiology, has performed some of the initial procedures using the new Journey Guidewire, including a live case at the recent Transcatheter Cardiovascular Therapeutics scientific symposium.
“In my experience, the Journey Guidewire provides exceptional torque and flexibility, particularly in difficult cases involving small vessels or tortuous anatomy,” said Benenati. “This highly durable guidewire offers outstanding precision and tracking to help access the toughest peripheral lesions.”
The Journey Guidewire builds on Boston Scientific’s advanced guidewire technology used in coronary and neurovascular interventions. It features a micro-cut nitinol sleeve designed to provide efficient transmission of torque energy for more precise turn-by-turn response and control compared to conventional spring-coil guidewires. The nitinol distal core and hydrophilic coating are designed to enhance wire durability, tactile response and device delivery for improved overall performance.
“The Journey Guidewire reflects Boston Scientific’s commitment to providing physicians the most advanced solutions for peripheral interventions,” said Joe Fitzgerald, senior vice president and president of Boston Scientific’s Endovascular Unit. “Journey enhances our below-the-knee portfolio, which includes a number of leading products to treat this challenging anatomy.”